Portfolio Prof. Dr. Rupert Handgretinger

Person data

Academic title:
Prof. Dr.
Name:
Rupert Handgretinger
Organizational unit:
Faculty of Medicine
University of Tübingen

Contact data

Curriculum vitae

Scientific Career History


1979-1986 Medical School, Universities of Essen and Tübingen, Germany
21.05.1986 Approbation (Certified physician),
  issuing authority: Regierungspräsidium Stuttgart
1986-1989 Research Fellow of the "Mildred Scheel Cancer Aid", University of Tübingen
1989 University of Tübingen, MD Thesis: 
  Untersuchungen zum Einsatz von Interleukin 2 in der Behandlung des metasierenden Neuroblastoms
1989-1994 Pediatric Residency, Children`s University Hospital, Tübingen
1994 German Board of Pediatrics
1996 University of Tübingen, Habilitation ( Postdoctoral thesis in Pediatrics):
  Untersuchungen zur Immuntherapie mit monoklonalen Antikörpern beim metastasierenden Neuroblastom
1989-2000 Director of the Stem Cell Processing Laboratory at the Children`s University Hospital, Tübingen
1994-2000 Head Physician, General Pediatrics and Division of Hematology/Oncology, University Hospital Tübingen
2000-2005 Full Faculty Member and Director of the Division of Stem Cell Transplantation, Department of Hematology/Oncology, St. Jude Children`s Research Hospital, Memphis, TN, USA
2000-2005 Professor, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN, USA
2005 to present Professor, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA
2005 to present Medical Director, Department of General Pediatrics and Hematology/Oncology, Children`s University Hospital Tübingen, Germany
2011 to present Chairman, Children`s University Hospital Tübingen, Germany

Projects

2019 - 2025
Hans-Georg Rammensee, Lars Zender, Bernd Pichler
Deutsche Forschungsgemeinschaft e.V. (DFG)
2018 - 2020
Rupert Handgretinger
Deutsche José Carreras Leukämie-Stiftung e.V.
2018 - 2020
Ines Brecht
Europäische Kommission
2018 - 2019
Alexander Weber, Jasmin Kümmerle-Deschner
2017 - 2018
Peter Lang
Miltenyi Biotech GmbH
2017 - 2020
Gerhard Binder, Roland Schweizer, Julian Ziegler
2017 - 2020
Patrick Schlegel, Christian Seitz
Hilfe für kranke Kinder e.V.
2016 - 2017
Rupert Handgretinger
Stiftung des Fördervereins für krebskranke Kinder Tübingen
2016 - 2018
Peter Lang
Deutsches Krebsforschungszentrum (DKFZ)
2016 - 2018
Peter Lang
Deutsches Krebsforschungszentrum (DKFZ)
2016
Rupert Handgretinger
Alexion Pharma Germany GmbH
2016
Rupert Handgretinger
Stiftung des Fördervereins für krebskranke Kinder Tübingen
2016 - 2019
Ines Brecht
Deutsche Kinderkrebsstiftung
2016 - 2021
Rupert Handgretinger
2015 - 2017
Rupert Handgretinger
Amgen GmbH
2015
Rupert Handgretinger
Stiftung des Fördervereins für krebskranke Kinder Tübingen
2015 - 2024
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)
2015 - 2024
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)
2015
Rupert Handgretinger
Hexal AG
2015 - 2016
Peter Lang
RIEMSER Pharma GmbH
2015 - 2016
Rupert Handgretinger
Stiftung des Fördervereins für krebskranke Kinder Tübingen
Martin-Weller-Stiftung
2015 - 2016
Peter Lang
Miltenyi Biotech GmbH
2014 - 2020
Peter Lang
APEIRON Biologics AG
2000 - 2019
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)

Publications

Help

will be deleted permanently. This cannot be undone.